Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 483

1.

Retraction notice to "Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury" [Int. J. Cardiol. 163 (2013) 326-334].

Barry SP, Ounzain S, McCormick J, Scarabelli TM, Chen-Scarabelli C, Saravolatz LII, Faggian G, Mazzucco A, Suzuki H, Thiemermann C, Knight RA, Latchman DS, Stephanou A.

Int J Cardiol. 2019 Jan 1;274:404. doi: 10.1016/j.ijcard.2018.10.031. No abstract available.

2.

ERK and the F-box protein β TRCP target STAT1 for degradation.

Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A.

J Biol Chem. 2018 Mar 30;293(13):4954. doi: 10.1074/jbc.W118.002740. No abstract available.

3.

Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.

Hudson CD, Morris PJ, Latchman DS, Budhram-Mahadeo VS.

J Biol Chem. 2016 Jul 22;291(30):15909. doi: 10.1074/jbc.A116.408679. No abstract available.

4.

Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.

Ripoll VM, Lambrianides A, Pierangeli SS, Poulton K, Ioannou Y, Heywood WE, Mills K, Latchman DS, Isenberg DA, Rahman A, Giles IP.

Blood. 2014 Dec 11;124(25):3808-16. doi: 10.1182/blood-2014-05-577569. Epub 2014 Oct 9.

5.

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis.

Pericleous C, Ruiz-Limón P, Romay-Penabad Z, Marín AC, Garza-Garcia A, Murfitt L, Driscoll PC, Latchman DS, Isenberg DA, Giles I, Ioannou Y, Rahman A, Pierangeli SS.

Rheumatology (Oxford). 2015 Apr;54(4):722-7. doi: 10.1093/rheumatology/keu360. Epub 2014 Sep 30.

6.

Signal transducer and activator of transcription-1 localizes to the mitochondria and modulates mitophagy.

Bourke LT, Knight RA, Latchman DS, Stephanou A, McCormick J.

JAKSTAT. 2013 Oct 1;2(4):e25666. doi: 10.4161/jkst.25666. Epub 2013 Jul 15.

7.

Regulation of myocardial interleukin-6 expression by p53 and STAT1.

Carroll CJ, Sayan BS, Bailey SG, McCormick J, Stephanou A, Latchman DS, Townsend PA.

J Interferon Cytokine Res. 2013 Sep;33(9):542-8. doi: 10.1089/jir.2012.0165. Epub 2013 May 15.

PMID:
23675777
8.

Endothelial microparticle release is stimulated in vitro by purified IgG from patients with the antiphospholipid syndrome.

Pericleous C, Clarke LA, Brogan PA, Latchman DS, Isenberg DA, Ioannou Y, Giles IP, Rahman A.

Thromb Haemost. 2013 Jan;109(1):72-8. doi: 10.1160/TH12-05-0346. Epub 2012 Nov 15.

PMID:
23152159
9.

Autophagy in the stress-induced myocardium.

McCormick J, Knight RA, Barry SP, Scarabelli TM, Abounit K, Latchman DS, Stephanou A.

Front Biosci (Elite Ed). 2012 Jan 1;4:2131-41. Review.

PMID:
22202025
10.

Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury.

Barry SP, Ounzain S, McCormick J, Scarabelli TM, Chen-Scarabelli C, Saravolatz LII, Faggian G, Mazzucco A, Suzuki H, Thiemermann C, Knight RA, Latchman DS, Stephanou A.

Int J Cardiol. 2013 Mar 10;163(3):326-334. doi: 10.1016/j.ijcard.2011.08.849. Epub 2011 Oct 24. Retraction in: Int J Cardiol. 2019 Jan 1;274:404.

11.

The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications.

Ulgen BO, Field MG, Qureshi W, Knight RA, Stephanou A, Latchman DS, Vasquez D, Barry SP, Saravolatz L 2nd, Scarabelli GM, Faggian G, Mazzucco A, Saravolatz L, Chen-Scarabelli C, Scarabelli TM.

Recent Pat Cardiovasc Drug Discov. 2011 May;6(2):123-32. Review.

PMID:
21599619
12.

STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy.

McCormick J, Suleman N, Scarabelli TM, Knight RA, Latchman DS, Stephanou A.

J Cell Mol Med. 2012 Feb;16(2):386-93. doi: 10.1111/j.1582-4934.2011.01323.x.

13.

Transcriptional modulation of heat-shock protein gene expression.

Stephanou A, Latchman DS.

Biochem Res Int. 2011;2011:238601. doi: 10.1155/2011/238601. Epub 2010 Sep 15.

14.

STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest.

Dimco G, Knight RA, Latchman DS, Stephanou A.

Cell Cycle. 2010 Dec 1;9(23):4638-49. Epub 2010 Dec 1. Erratum in: Cell Cycle. 2016 May 18;15(10):1387-8.

PMID:
21084836
15.

Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injury.

Carroll CJ, Suleman N, Davidson SM, Faulkes DJ, Diss JK, Knight R, Stephanou A, Latchman DS, Townsend PA.

Int J Biochem Cell Biol. 2011 Jan;43(1):74-9. doi: 10.1016/j.biocel.2010.09.020. Epub 2010 Oct 29.

PMID:
20932935
16.

STAT3 modulates the DNA damage response pathway.

Barry SP, Townsend PA, Knight RA, Scarabelli TM, Latchman DS, Stephanou A.

Int J Exp Pathol. 2010 Dec;91(6):506-14. doi: 10.1111/j.1365-2613.2010.00734.x. Epub 2010 Aug 27.

17.

Cell-specific regulation of the pro-survival Brn-3b transcription factor by microRNAs.

Calissano M, Latchman DS.

Mol Cell Neurosci. 2010 Dec;45(4):317-23. doi: 10.1016/j.mcn.2010.06.015. Epub 2010 Jul 4.

PMID:
20609388
18.

New targets of urocortin-mediated cardioprotection.

Barry SP, Lawrence KM, McCormick J, Soond SM, Hubank M, Eaton S, Sivarajah A, Scarabelli TM, Knight RA, Thiemermann C, Latchman DS, Townsend PA, Stephanou A.

J Mol Endocrinol. 2010 Aug;45(2):69-85. doi: 10.1677/JME-09-0148. Epub 2010 May 25.

19.

Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.

Lambrianides A, Carroll CJ, Pierangeli SS, Pericleous C, Branch W, Rice J, Latchman DS, Townsend P, Isenberg DA, Rahman A, Giles IP.

J Immunol. 2010 Jun 15;184(12):6622-8. doi: 10.4049/jimmunol.0902765. Epub 2010 May 17.

20.

Estrogen and non-genomic upregulation of voltage-gated Na(+) channel activity in MDA-MB-231 human breast cancer cells: role in adhesion.

Fraser SP, Ozerlat-Gunduz I, Onkal R, Diss JK, Latchman DS, Djamgoz MB.

J Cell Physiol. 2010 Aug;224(2):527-39. doi: 10.1002/jcp.22154.

PMID:
20432453
21.

EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.

Gascoyne DM, Dunne J, Behjati S, Sebire NJ, Anderson J, Latchman DS.

Oncogene. 2010 May 27;29(21):3134-45. doi: 10.1038/onc.2010.72. Epub 2010 Mar 29.

PMID:
20348952
22.

A simple technique for the prediction of interacting proteins reveals a direct Brn-3a-androgen receptor interaction.

Berwick DC, Diss JK, Budhram-Mahadeo VS, Latchman DS.

J Biol Chem. 2010 May 14;285(20):15286-95. doi: 10.1074/jbc.M109.071456. Epub 2010 Mar 12.

23.

The cellular transcription factor Brn-3a and the smoking-related substance nicotine interact to regulate the activity of the HPV URR in the cervix.

Ndisang D, Khan A, Lorenzato F, Sindos M, Singer A, Latchman DS.

Oncogene. 2010 May 6;29(18):2701-11. doi: 10.1038/onc.2010.33. Epub 2010 Mar 1.

PMID:
20190800
24.

Green tea polyphenol epigallocatechin gallate inhibits cell signaling by inducing SOCS1 gene expression.

Ripley BJ, Fujimoto M, Serada S, Ohkawara T, Nishikawa T, Terabe F, Matsukawa Y, Stephanou A, Knight RA, Isenberg DA, Latchman DS, Kishimoto T, Naka T.

Int Immunol. 2010 May;22(5):359-66. doi: 10.1093/intimm/dxq015. Epub 2010 Feb 26.

PMID:
20190037
25.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.

Arthritis Rheum. 2010 Mar;62(3):845-54. doi: 10.1002/art.27286.

26.

Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia.

van der Weerd L, Tariq Akbar M, Aron Badin R, Valentim LM, Thomas DL, Wells DJ, Latchman DS, Gadian DG, Lythgoe MF, de Belleroche JS.

J Cereb Blood Flow Metab. 2010 Apr;30(4):849-56. doi: 10.1038/jcbfm.2009.249. Epub 2009 Dec 9.

27.

Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease.

Francis YI, Fà M, Ashraf H, Zhang H, Staniszewski A, Latchman DS, Arancio O.

J Alzheimers Dis. 2009;18(1):131-9. doi: 10.3233/JAD-2009-1134.

PMID:
19625751
28.

STAT3 deletion sensitizes cells to oxidative stress.

Barry SP, Townsend PA, McCormick J, Knight RA, Scarabelli TM, Latchman DS, Stephanou A.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):324-9. doi: 10.1016/j.bbrc.2009.05.051. Epub 2009 May 18.

29.

Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.

Sleiman PM, Healy DG, Muqit MM, Yang YX, Van Der Brug M, Holton JL, Revesz T, Quinn NP, Bhatia K, Diss JK, Lees AJ, Cookson MR, Latchman DS, Wood NW.

Neurosci Lett. 2009 Jun 26;457(2):75-9. doi: 10.1016/j.neulet.2009.03.021. Epub 2009 Mar 11.

30.

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.

Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, Abramov AY.

Mol Cell. 2009 Mar 13;33(5):627-38. doi: 10.1016/j.molcel.2009.02.013.

31.

In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept.

Ioannou Y, Romay-Penabad Z, Pericleous C, Giles I, Papalardo E, Vargas G, Shilagard T, Latchman DS, Isenberg DA, Rahman A, Pierangeli S.

J Thromb Haemost. 2009 May;7(5):833-42. doi: 10.1111/j.1538-7836.2009.03316.x. Epub 2009 Feb 12.

32.

Molecular basis of Parkinson's disease.

Yang YX, Wood NW, Latchman DS.

Neuroreport. 2009 Jan 28;20(2):150-6. doi: 10.1097/WNR.0b013e32831c50df. Review.

PMID:
19151598
33.

Regulation of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiation.

Berwick DC, Calissano M, Corness JD, Cook SJ, Latchman DS.

Brain Res. 2009 Feb 23;1256:8-18. doi: 10.1016/j.brainres.2008.12.009. Epub 2008 Dec 11.

PMID:
19135033
34.

The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds.

Ndisang D, Lorenzato F, Sindos M, Khan A, Singer A, Latchman DS.

Obstet Gynecol Int. 2009;2009:359457. doi: 10.1155/2009/359457. Epub 2010 Mar 9.

35.

Protective effect of post-ischaemic viral delivery of heat shock proteins in vivo.

Badin RA, Modo M, Cheetham M, Thomas DL, Gadian DG, Latchman DS, Lythgoe MF.

J Cereb Blood Flow Metab. 2009 Feb;29(2):254-63. doi: 10.1038/jcbfm.2008.106. Epub 2008 Sep 10.

36.

Amino acid supplementation differentially modulates STAT1 and STAT3 activation in the myocardium exposed to ischemia/reperfusion injury.

Scarabelli TM, Townsend PA, Chen Scarabelli C, Yuan Z, McCauley RB, Di Rezze J, Patel D, Putt J, Allebban Z, Abboud J, Chilukuri K, Gardin J, Saravolatz L, Knight RA, Latchman DS, Stephanou A.

Am J Cardiol. 2008 Jun 2;101(11A):63E-68E. doi: 10.1016/j.amjcard.2008.03.003.

PMID:
18514629
37.

Nurr1 transcriptionally regulates the expression of alpha-synuclein.

Yang YX, Latchman DS.

Neuroreport. 2008 May 28;19(8):867-71. doi: 10.1097/WNR.0b013e3282ffda48.

PMID:
18463503
38.

Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription.

Hudson CD, Sayan AE, Melino G, Knight RA, Latchman DS, Budhram-Mahadeo V.

Cell Death Differ. 2008 Aug;15(8):1266-78. doi: 10.1038/cdd.2008.45. Epub 2008 Apr 18.

39.

p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.

Soond SM, Barry SP, Melino G, Knight RA, Latchman DS, Stephanou A.

Cell Cycle. 2008 May 1;7(9):1214-23. Epub 2008 Feb 15.

PMID:
18418051
40.

ERK and the F-box protein betaTRCP target STAT1 for degradation.

Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A.

J Biol Chem. 2008 Jun 6;283(23):16077-83. doi: 10.1074/jbc.M800384200. Epub 2008 Mar 31. Retraction in: J Biol Chem. 2018 Mar 30;293(13):4954.

41.

Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression.

Farooqui-Kabir SR, Diss JK, Henderson D, Marber MS, Latchman DS, Budhram-Mahadeo V, Heads RJ.

Cell Stress Chaperones. 2008 Sep;13(3):297-312. doi: 10.1007/s12192-008-0028-2. Epub 2008 Mar 27.

42.

Gene expression studies on bio-electrosprayed primary cardiac myocytes.

Barry SP, Jayasinghe SN, Pericleous C, Hubank M, Latchman DS, Stephanou A.

Biotechnol J. 2008 Apr;3(4):530-5. doi: 10.1002/biot.200700266.

PMID:
18293311
43.

Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression.

Sharp PS, Akbar MT, Bouri S, Senda A, Joshi K, Chen HJ, Latchman DS, Wells DJ, de Belleroche J.

Neurobiol Dis. 2008 Apr;30(1):42-55. doi: 10.1016/j.nbd.2007.12.002. Epub 2007 Dec 23.

PMID:
18255302
44.

Identification and characterization of the promoter region of the Nav1.7 voltage-gated sodium channel gene (SCN9A).

Diss JK, Calissano M, Gascoyne D, Djamgoz MB, Latchman DS.

Mol Cell Neurosci. 2008 Mar;37(3):537-47. doi: 10.1016/j.mcn.2007.12.002. Epub 2007 Dec 15.

PMID:
18249135
45.

Beta-subunits of voltage-gated sodium channels in human prostate cancer: quantitative in vitro and in vivo analyses of mRNA expression.

Diss JK, Fraser SP, Walker MM, Patel A, Latchman DS, Djamgoz MB.

Prostate Cancer Prostatic Dis. 2008;11(4):325-33. Epub 2007 Sep 25.

PMID:
17893701
46.

The heat shock proteins and plastic surgery.

Wagstaff MJ, Shah M, McGrouther DA, Latchman DS.

J Plast Reconstr Aesthet Surg. 2007;60(9):974-82. Epub 2006 Jun 12. Review.

PMID:
17662462
47.

Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells.

Budhram-Mahadeo VS, Irshad S, Bowen S, Lee SA, Samady L, Tonini GP, Latchman DS.

Oncogene. 2008 Jan 3;27(1):145-54. Epub 2007 Jul 16.

PMID:
17637757
48.

Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.

Lambrianides A, Giles I, Ioannou Y, Mason L, Latchman DS, Manson JJ, Isenberg DA, Rahman A.

Arthritis Rheum. 2007 Jul;56(7):2392-401.

49.

Post-transcriptional regulation of the Brn-3b transcription factor in differentiating neuroblastoma cells.

Calissano M, Diss JK, Latchman DS.

FEBS Lett. 2007 May 29;581(13):2490-6. Epub 2007 May 2.

50.

Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.

Townsend PA, Davidson SM, Clarke SJ, Khaliulin I, Carroll CJ, Scarabelli TM, Knight RA, Stephanou A, Latchman DS, Halestrap AP.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H928-38. Epub 2007 May 4.

Supplemental Content

Loading ...
Support Center